Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Lyft in the offering, and Goodwin Procter represented the initial purchasers. Lyft, Inc. (“Lyft”) (NASDAQ: LYFT) closed its offering of 0.625%...
You must be a Standard 1 Year member to access this content.
Goodwin advised Rocket Lab USA, Inc. on the offering. Rocket Lab USA, Inc. (Nasdaq: RKLB), a global leader in launch services and space systems, announced the...
You must be a Standard 1 Year member to access this content.
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
You must be a Standard 1 Year member to access this content.
Goodwin advised 1X Technologies on the funding round. 1X Technologies announced the closing of its $100 million Series B financing round that included participation from EQT...
You must be a Standard 1 Year member to access this content.
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
You must be a Standard 1 Year member to access this content.
Goodwin advised Isomorphic Labs on its strategic research collaboration with Novartis. Isomorphic Labs has signed a strategic research collaboration with Novartis to discover small molecule therapeutics against...
You must be a Standard 1 Year member to access this content.
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
You must be a Standard 1 Year member to access this content.
Goodwin advised SpringWorks Therapeutics, Inc. on the offering. American precision medicine company SpringWorks Therapeutics (Nasdaq: SWTX) has closed a public offering of 10,905,171 shares of its common...
You must be a Standard 1 Year member to access this content.
Leerink Partners is acting as exclusive financial advisor and Gibson, Dunn & Crutcher LLP is acting as legal counsel to Rain. Goodwin Procter LLP is acting...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
You must be a Standard 1 Year member to access this content.
Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering. Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due...
You must be a Standard 1 Year member to access this content.
